| Months | 1 | 2 | 3 | 4 | 5 | 6 |
|---|---|---|---|---|---|---|
| Patients at risk (n) | 12 | 10 | 8 | 4 | 4 | 3 |
| Patients returning questionnaires (n) | 12 | 10 | 6 | 2 | 2 | 1 |
| Patients reporting pain (n, %) | 7 (58%) | 5 (50%) | 1 (17%) | 0 | 0 | 0 |
| Patients whose completion was censored1 due to end of study (n) | 0 | 0 | 1 | 4 | 4 | 5 |
| Performance status2 (n, %) | ||||||
| 0 | 1 (14%) | 3 (60%) | - | - | - | - |
| 1 | 3 (43%) | 1 (20%) | - | - | - | - |
| 2 | 3 (43%) | 1 (20%) | 1 | - | - | - |
| 3 or 4 | - | - | - | - | - | - |
1Censored are the patients whose follow up was ceased due to end of the study.
2The displayed performance status refers only to patients with pain, who therefore would be EUS-CPN candidates, if a clinical trial was running.